Skip to main content
Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.580
-0.060 (-3.66%)
At close: Feb 27, 2026, 4:00 PM EST
1.500
-0.080 (-5.06%)
After-hours: Feb 27, 2026, 7:53 PM EST

Pulmonx Revenue

Pulmonx had revenue of $21.50M in the quarter ending September 30, 2025, with 5.47% growth. This brings the company's revenue in the last twelve months to $91.66M, up 15.59% year-over-year. In the year 2024, Pulmonx had annual revenue of $83.79M with 22.01% growth.

Revenue (ttm)
$91.66M
Revenue Growth
+15.59%
P/S Ratio
0.71
Revenue / Employee
$314,997
Employees
291
Market Cap
65.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 436.97M
Xtant Medical Holdings 133.08M
Outset Medical 119.48M
MaxCyte 34.42M
Baird Medical Investment Holdings 31.86M
electroCore 29.84M
Sensus Healthcare 27.48M
QT Imaging Holdings 18.93M
Revenue Rankings

LUNG News

More News